Natural compounds in the treatment of osteosarcoma: just chemotherapy adjuvants? or is there much more?

Read full text
Authors: Daniele Bellavia, Flores Naselli, Paola Miriam Russo, Viviana Costa, Angela De Luca, Lavinia Raimondi, Fabio Caradonna, Gianluca Giavaresi
Cited by: 1
References: 111

Abstract

Osteosarcoma is the most common type of bone tumor. Different therapeutic approaches are used in the management of osteosarcoma, where surgery is most often performed, often preceded and followed by chemotherapy, which however has serious short- and long-term side effects. Recently, much attention has been paid to natural compounds that can determine cell death of tumor. Some have a direct cytotoxic effect, and they also can reduce tumor and metastatic activity. Furthermore, it described how these molecules can also interact with elective chemotherapy against osteosarcoma. In this review, we have analysed the last decade literature, highlighting both the studies that have a direct cytotoxic effect on osteosarcoma, and those that are used as adjuvants to chemotherapy, allowing to reduce treatment doses, limiting the side effects. The comparison between the different studies have led to relevant considerations on the study standardization.

Fields of Study & Subjects

Bioactive Compounds and Antitumor Agents Beetle Biology and Toxicology Studies Flavonoids in Medical Research

Publication details

Journal / source
Cancer Cell International
Publisher
Springer Science and Business Media LLC
Volume
26
Issue
1
Publication date
9 February 2026
Language
EN